Philippine President Duterte Ready to be First to Test Russian COVID-19 Vaccine

© AFP 2022 / TOTO LOZANOThis photo taken April 8, 2020 and received from the Presidential Photo Division on April 9, Philippine President Rodrigo Duterte, wearing a face mask, presides over a meeting with members of the inter-Agency Task Force on the Emerging Infectious Diseases (IATF-EID) in Malacanang Palace in Manila.
This photo taken April 8, 2020 and received from the Presidential Photo Division on April 9, Philippine President Rodrigo Duterte, wearing a face mask, presides over a meeting with members of the inter-Agency Task Force on the Emerging Infectious Diseases (IATF-EID) in Malacanang Palace in Manila. - Sputnik International
Subscribe
US
India
Global
The Asian island nation previously confirmed at least 136,000 COVID-19 cases and a death toll of 2,294. The daily coronavirus increase in the Philippines has reached nearly 7,000, making it the 6th-highest spike in the world and the highest in the region.

Philippine President Rodrigo Duterte has praised a COVID-19 vaccine under development by the Russian Direct Investment Fund (RDIF), stressing that he is ready to be the first subject of the trials in his own country.

"I will tell [Russian] President Putin that I have huge trust in your studies in combating COVID and I believe that the vaccine that you have produced is really good for humanity", Duterte stated on Monday, adding that he can be "the first they can experiment on".
© Sputnik / Ilya Pitalev / Go to the photo bankTwo Russian universities are working on the development of a vaccine
Philippine President Duterte Ready to be First to Test Russian COVID-19 Vaccine - Sputnik International
Two Russian universities are working on the development of a vaccine

On Tuesday, Duterte's office also stated the Philippines stands ready to work with Russia on vaccine trials, supply, and production.

In the meantime, RDIF CEO Kirill Dmitriev on Monday confirmed that the fund is ready to hold clinical trials for a coronavirus vaccine in the Philippines in August.

Clinical trials of the vaccine in Russia began on 18 June at two institutions, the Burdenko Main Military Clinical Hospital and the Sechenov First Moscow State Medical University. All 38 of the participants developed immunity from the virus. The first group was discharged on 15 July, the second group on 20 July.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала